Table 2.
Case series of PHA
| Author (year) | Country | Number | Operation | Other Treatment | Median survival |
|---|---|---|---|---|---|
| Molina et al. [1] (2003) | America | 5 | 2 operation + chemotherapy, 1 operation | 2 conservative | 2 months |
| Weitz et al. [23] (2007) | America | 5 | 3 operation (2 potentially curative) | 2 no operation | n.a.a |
| Kim et al. [13] (2009) | Korea | 5 | – | 4 chemotherapy, 1 conservative | 3 months |
| Matthaei et al. [5] (2009) | Germany | 5 | 5 operation | – | 30 months |
| Park et al. [9] (2009) | Korea | 6 | – | 4 TACE, 2 TAE | 3.5 months |
| Zhou et al. [12] (2010) | China | 6 | 1 operation, 5 operation + TACE | – | 12 months |
| Huang et al. [24] (2011) | China | 9 | 3 operation + chemotherapy, 1TAE + operation | 4 conservative, 1 TAE + TACE | 4 months |
| Chi et al. [25] (2011) | China | 7 | 3 operation, 2 liver transplantation | 2 conservative | 6.5 months |
| Duan et al. [7] (2012) | China | 6 |
5 operation, 1 operation + chemotherapy 1 operation + chemotherapy, |
– | 40.5 months |
| Bruegel et al. [21] (2012) | Germany | 7 | 1 operation | 4 chemotherapy | 16 months |
| Hur et al. [26] (2015) | Korea | 8 | 1 operation | 1 TACE, 4 chemotherapy, 2 conservative | 214 days |
| Huang et al. [14] (2016) | Taiwan | 6 | 1 operation | 1 chemotherapy, 1 chemotherapy + cyberknife, 1 cyberknife, 2 conservative | n.a. |
| Zhu et al. [27] (2015) | China | 2 | 2 operation | – | 12 months |
| Present study (2018) | Germany | 9 | 9 operation | – | 18 months |
n.a. not available; aboth patients with potentially curative resection died within 11 months after surgery